Company: CI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001739940-25-000009
Chunk: 798

Company: Cigna Group
Filing Date: 2025-02-27
Form: 10-K
Item: Item 14
Chunk 798
---
 its debt covenants as of December 31, 2024.Note 3 - The Company's intercompany receivables consist primarily of net intercompany loan amounts due from Evernorth Health, Inc. of $8.5 billion as of December 31, 2024 and 2023. Interest income on the loan receivable was accrued at an average rate of 5.50% in 2024.The Company's intercompany payables primarily reflect intercompany balances due to affiliates as of December 31, 2024. During the year ended December 31, 2024, the Company settled the majority of outstanding intercompany payables via non-cash capital transactions.Note 4 - The Company guaranteed approximately $9.4 billion primarily related to intercompany indebtedness and financial obligations of certain direct and indirect wholly-owned subsidiaries. There were immaterial liabilities required for these guarantees as of December 31, 2024. Note 5 - In February 2024, as part of our existing share repurchase program, we entered into separate accelerated share repurchase agreements with Deutsche Bank AG and Bank of America, N.A. to repurchase $3.2 billion of common stock in aggregate. The total number of shares of our common stock repurchased under the agreements was approximately 9.3 million.

FS-6

 THE CIGNA GROUP AND SUBSIDIARIES

SCHEDULE IIVALUATION AND QUALIFYING ACCOUNTS AND RESERVES(In millions)Balance at Beginning of YearCharged (Credited) to Costs and ExpensesCharged (Credited) to Other AccountsOther DeductionsBalance at End of YearDescription2024     Investment asset valuation reservesAvailable-for-sale debt securities$33 $87 $— $(9)$111 Commercial mortgage loans$31 $(1)$— $— $30 Accounts receivable, net$163 $176 $(1)$(152)$186 Deferred tax asset valuation allowance$1,498 $866 $(32)$— $2,332 Reinsurance recoverables $35 $(5)$— $— $30 2023Investment asset valuation reservesAvailable-for-sale debt securities$44 $11 $— $(22)$33 Commercial mortgage loans$21 $10 $— $— $31 Accounts receivable, net$160 $90 $1 $(88)$163 Deferred tax asset valuation allowance